Rituximab PK and PD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarity PAGE 30 (2022) Abstr 10136 Svensson RJ, Ooi QX, Friberg LE, Lopez Lazaro L, Hansson E. ConferenceOncologyPharmacometrics Pharmetheus Affiliates Senior Director, MIDD Consultant Qing Xi Ooi See bio Scientific Advisor Lena Friberg See bio Senior Director, Regulatory Affairs Emma Hansson See bio Director, Quality Control & Medical Writing Consultant Viviana Moroso See bio